Clinical Trials Directory

Trials / Unknown

UnknownNCT00943891

A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (planned)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

1. To determine the association between LVD and clinico-pathologic variables in archived colorectal cancer and Nasopharyngeal carcinoma specimens 2. To determine the association between VEGF-C,-D expression with COX-2 expression and clinico-pathologic variables in colorectal cancer and Nasopharyngeal carcinoma 3. To determine the effect of celecoxib on lymphangiogenesis in Nasopharyngeal carcinoma Lymphangiogenesis and factors modulating lymphangiogenesis are associated with clinico-pathological outcome in Nasopharyngeal carcinoma and colorectal cancer. Celecoxib down-regulates lymphangiogenesis Archival colorectal cancer and Nasopharyngeal carcinoma tumor specimens will be obtained from the Department of Pathology. To determine the effect of celecoxib on lymphangiogenesis in Nasopharyngeal carcinoma, the investigators intend to analyze archived specimens collected in a previously conducted study. Colorectal tumor and nodal specimens and Nasopharyngeal carcinoma primary will be examined for MVD, LVD and growth factor expression using established haematoxylin and eosin and immunohistochemical techniques. Quantification of LVD and MVD shall be performed by two pathologists blinded to clinico-pathological variables using standardised methods.

Conditions

Interventions

TypeNameDescription
PROCEDURETumor biopsies

Timeline

Start date
2008-07-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2009-07-22
Last updated
2014-01-22

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT00943891. Inclusion in this directory is not an endorsement.